Member Info for Fanti

That was a coup, Num4.
Great publicity yet the benefit of data. Id trust Tim if he came up with such splendid idea.

he states: „We are very pleased to have recently received a UKRI grant to test this hypothesis .“

Given the acknowledgement results might be positiv so far.

Just to gain a fraction of the pie is good enough to me.

Takeda is a Japanese drug maker and on a different mission anyway.
Xhttps://www.takeda.com/covid-19-information-center/

Exiting times ahead.
Thanks Toth, your research and knowledge is much appreciated. What about Takeda? Just came across this link. Are they a serious competition?
https://pubmed.ncbi.nlm.nih.gov/24386992/

https://www.aljazeera.com/economy/2020/12/11/research-finds-5-genes-linked-to-most-severe-form-of-covid-19

Good morning Ladies and Gentleman

looks like we seem fairly rated with a 160% so far.
https://quoteddata.com/wp-content/uploads/2020/06/200624-Sareum-MC.pdf

At least Sierra comes to terms.

http://investor.sierraoncology.com/2020-12-01-Sierra-Oncology-to-Host-KOL-Panel-Event-to-Discuss-Updated-Phase-3-Myelofibrosis-Data-Presented-at-ASH

And nowadays covered to who ever this is.
One klick back to come up with Sareum.

https://tracxn.com/tracxninvestors

Kind of a coverage back in 2008. Thereafter the big should know about us. An update actually was nice.

https://www.edisoninvestmentresearch.com/?ACT=18&ID=1195

Based in Rockville, Maryland, OncoImmune is a
privately-held, clinical-stage biopharmaceutical
company that is actively engaged in the discovery
and development of biopharmaceuticals for the
treatment of cancer and autoimmune disease.

I wonder if this or any other blue chip in general was possibly interested in a joint venture with our mysterious Chinese speciality firm who develop, manufacture and commercialize drugs?

at, of course.

A nasal spray formulated by the University of Birmingham

https://obn.org.uk/News/Latest-News/entryid/2476

Which could be a good thing, nowadays.
If it came to a vote re a possible merger, at least everybody had a chance to a personal vote and misses not out, because of the non arrival at the site.

More likely.
„Urged to vote electronically“ may relate to investors rights only and refer to legal purposes only. IMO

Morning lads, silly me, but what’s wrong with a royalties pricing model up until 2033, if I get this right?

Stoney, many thanks for your interpretation lately. Much appreciated.

Given the opportunity, I will thank this fantastic board and it’s people. Great surprise when my little holding went eventually green. After years.

Thanks.

What to make of Merck?

https://cancerres.aacrjournals.org/content/80/16_Supplement/LB-121

Speaking of 12,000£ / 25k £ capital stock minimum british law to establish a company? plus a big Fiserv capital injection and stock plus financial instruments / letter of intent and options ? launched and signed by YESIIs, still outstanding, LOL, payable within a month, to crowdfund and secure the Moni bid and buy.

You caught me. To change the subject. Do you get MVN, Barclays & CO's yesterday's and today's further buying to squeeze another 50,000£, my guess? My trading is simply poor watching that. Missing out great opportunities. Always.

some time, of course. Typo.